Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment

Developmental Medicine and Child Neurology

Volumn 46, Issue 11, 2004, Pages 771-775

  Phillips, Louise ^a   Appleton, Richard E ^a  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE; MELATONIN; PLACEBO;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADOLESCENT; ADULT; AMENORRHEA; CHILD; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONVULSION; DEVELOPMENTAL DISORDER; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FEMALE; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MOOD DISORDER; NAUSEA; NERVOUS SYSTEM DEVELOPMENT; NIGHT SLEEP; PRECOCIOUS PUBERTY; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; REVIEW; SEIZURE; SLEEP DISORDER; SLEEP TIME; SLEEP WAKING CYCLE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WAKEFULNESS;

ANTIOXIDANTS; BRAIN; CHILD; DEVELOPMENTAL DISABILITIES; HUMANS; MELATONIN; SLEEP DISORDERS; WAKEFULNESS;

EID: 7944232485     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S001216220400132X     Document Type: Review

References (19)

1. Aldhous M, Franey C, Wright J, Arendt J. (1985) Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol 4: 517-521.
2. Alvarez B, Dahlitz MJ, Vignan J, Parkes JD. (1992) The delayed sleep-phase syndrome: clinical and investigative findings in 14 subjects. J Neurol Neurosurg Psychiatry 55: 665-670.
3. Brzezinski A. (1997) Melatonin in humans. N Engl J Med 336: 186-195.
4. Brzezinski A, Lynch HJ, Seibel MM, Deng MH, Nader TM, Wittman RJ. (1988) The circadian rhythm of plasma melatonin during the normal menstrual cycle and in amenorrhoeic women. J Clin Endocrinol Metab 66: 891-895.
5. Camfield P, Gordon K, Dooley J, Camfield C. (1996) Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six 'N of 1' trials. J Child Neurol 11: 341-343.
6. Dodge ND, Wilson GA. (2001) Melatonin for treatment of sleep disorders in children with developmental disabilities. J Child Neurol 16: 581-584.
7. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. (2002) Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 31: 140-149.
8. Hung JCC, Appleton RE, Nunn AJ, Rosenbloom L. (1998) The use of melatonin in the treatment of sleep disturbances in children with neurological or behavioural disorders. J Pediatr Pharm Prac 3: 250-256.
9. Jan JE, Espezel H, Appleton RE. (1994) The treatment of sleep disorders with melatonin. Dev Med Child Neurol 36: 97-107.
10. Jan JE, Freeman RD, Fast DK. (1999) Melatonin treatment of sleep-wake disorders in children and adolescents. Dev Med Child Neurol 41: 491-500.
11. Jan JE, Hamilton D, Seward N, Fast DK, Freeman RD, Laudon M. (2000) Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J Pineal Res 29: 34-39.
12. McArthur AJ, Budden SS. (1998) Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol 40: 186-192.
13. Miyamoto A, Oki J, Takahashi S, Okuno A. (1999) Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Retts syndrome. Brain Dev 21: 59-62.
14. O'Callaghan FJK, Clarke AA, Hancock E, Hunt A, Osborne JP. (1999) Use of melatonin to treat sleep disorders in tuberous sclerosis. Dev Med Child Neurol 41: 123-126.
15. Palm L, Blennow G, Wetterberg L. (1991) Correction of non-24-hour sleep-wake cycle by melatonin in a blind, retarded boy. Ann Neurol 29: 336-339.
16. Palm L, Blennow G, Wetterberg L. (1997) Long-term melatonin treatment in blind children and young adults with circadian sleep-wake disturbances. Dev Med Child Neurol 39: 319-325.
17. Puig-Domingo M, Webb SM, Serrano J, Peinado MA, Corcoy R, Ruscalleda J, Reiter RJ, de Leiva A. (1992) Melatonin-related hypogonadotropic hypogonadism. N Engl J Med 327: 1356-1359.
18. Sheldon SH. (1998) Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 351: 1254. (Letter)
19. Waldhauser F, Boepple PA, Schemper M, Mansfield MJ, Crowley WF, Jr. (1991) Serum melatonin in central precocious puberty is lower than age-matched prepubertal children. J Clin Endocrinol Metab 81: 793-796.